0001209191-21-071007.txt : 20211222
0001209191-21-071007.hdr.sgml : 20211222
20211222210020
ACCESSION NUMBER: 0001209191-21-071007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211220
FILED AS OF DATE: 20211222
DATE AS OF CHANGE: 20211222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Legault Pierre
CENTRAL INDEX KEY: 0001391045
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38916
FILM NUMBER: 211514584
MAIL ADDRESS:
STREET 1: P.O. BOX 1028
STREET 2: C/O STONE MANAGEMENT LLC
CITY: BERWYNE
STATE: PA
ZIP: 19312
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: B900 BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-20
0
0001761612
BICYCLE THERAPEUTICS plc
BCYC
0001391045
Legault Pierre
C/O BICYCLE THERAPEUTICS PLC
B900, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
1
0
0
0
Ordinary Shares
2021-12-20
4
M
0
7603
8.41
A
7603
D
Ordinary Shares
2021-12-20
4
S
0
7603
57.02
D
0
D
Ordinary Shares
2021-12-21
4
M
0
44537
8.44
A
44537
D
Ordinary Shares
2021-12-21
4
S
0
44537
57.11
D
0
D
Ordinary Shares
2021-12-22
4
M
0
97860
8.48
A
97860
D
Ordinary Shares
2021-12-22
4
S
0
97860
58.01
D
0
D
Stock Option (Right to Buy)
8.41
2021-12-20
4
M
0
7603
0.00
D
2029-04-25
Ordinary Shares
7603
165709
D
Stock Option (Right to Buy)
8.44
2021-12-21
4
M
0
44537
0.00
D
2029-04-25
Ordinary Shares
44537
121172
D
Stock Option (Right to Buy)
8.48
2021-12-22
4
M
0
97860
0.00
D
2029-04-25
Ordinary Shares
97860
23312
D
This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.319915 to GBP 1.00 as of December 20, 2021.
Shares were sold pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5) and (7).
This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.324735 to GBP 1.00 as of December 21, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.02 to $57.55 inclusive.
This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.331495 to GBP 1.00 as of December 22, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.50 inclusive.
This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022.
/s/ Lee Kalowski, Attorney-in-Fact
2021-12-22